{
    "prompt": "\n    If no matching FDA-approved drugs are found, please return message with the following JSON schema:\n    {\n        \"Status\": \"no_match\",\n        \"Message\": \"No drugs are FDA-approved for the provided context\"\n    }\n    \n    If FDA-approved drugs are found, please provide each treatment as a json format with the following JSON schema:\n    {\n        \"Status\": \"success\",\n        \"Treatment 1\": {\n            \"Disease Name\": ,\n            \"Disease Phase or Condition\": ,\n            \"Drug Name\": ,\n            \"Prior Treatment or Resistance Status\": ,\n            \"Genomic Features\": \n            \"FDA-approval status\":\n            \"Link to FDA-approved Label\":\n            }\n    }\n    Query: \n    The following is a summarized molecular profile from MSK-IMPACT.\n    Based on this profile, answer with the appropriate treatments for this patient in the format above.\n    Patient ID: P-0014703\nAge: 80\nGender: Female\nSample ID: P-0014703-T01-IM6\nGene Panel: IMPACT468\nCancer Type: Breast Invasive Ductal Carcinoma\nSample Type: Metastasis\nTumor Purity: 60.0%\n=============\nDNA Variants:\nBTK c.1328T>C (p.I443T) - in 16.00% of 948 reads\nGATA3 c.1097G>A (p.R366Q) - in 10.00% of 1280 reads\nMAP3K1 c.2109del (p.S704Qfs*21) - in 12.00% of 1328 reads\nMAP3K1 c.3460dup (p.A1154Gfs*6) - in 25.00% of 846 reads\nSLX4 c.3907G>A (p.E1303K) - in 17.00% of 2227 reads\nCNA Data:\nNo CNA data found.\nStructural Variants:\nNo structural variant data found.\n    ",
    "response": "{\n  \"Status\": \"no_match\",\n  \"Message\": \"No drugs are FDA-approved for the provided context\"\n}"
}